Jacqueline Kraveka to Antineoplastic Agents
This is a "connection" page, showing publications Jacqueline Kraveka has written about Antineoplastic Agents.
Connection Strength
0.721
-
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma. Cancer Rep (Hoboken). 2022 Nov; 5(11):e1616.
Score: 0.478
-
Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide. J Biol Chem. 2011 Jul 15; 286(28):24754-64.
Score: 0.224
-
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma. Cancer Med. 2015 Jun; 4(6):871-86.
Score: 0.018